Neoadjuvant combination of pazopanib or axitinib and programmed cell death protein-1-activated dendritic cell-cytokine-induced killer cells immunotherapy may facilitate surgery in patients with renal cell carcinoma - Zhang, Zhiling; Xiong, Longbin; Wu, Zeshen; Liu, Huiming; Ning, Kang; Peng, Yulu; Yu, Chunping; Ding, Ya; Weng, Desheng; Xia, Jianchuan; Jiang, Lijuan; Guo, Shengjie; et al. (Translational Andrology and Urology, 2021)